Dr Reddy's Laboratories Ltd (RDY) Stock Price, Quote, News & History

RDYNYSE
$13.27
-0.035-0.26%
Last update: Jun 11, 11:46 AM
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
56.76B
Investing Cash Flow (TTM)
-65.51B
Financing Cash Flow (TTM)
8.29B
Free Cash Flow (TTM)
18.33B
Capital Expenditure (TTM)
-38.42B
Net Change in Cash (TTM)
-468.00M

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$11.04B
PE Ratio (TTM)
24.56
PE Ratio (FWD)
24.75
PEG Ratio (TTM)
1.60
PS Ratio (TTM)
3.13
PB Ratio (TTM)
2.79
Earnings Yield % (TTM)
4.07%
Earnings Yield % (FWD)
4.04%
EV / EBITDA (TTM)
13.25
Price / EBITDA (TTM)
13.29
Price / Free Cash Flow (TTM)
57.41
Book Value / Share
$4.77

Company Debt

Total Debt
$75.14B
LT Debt
$12.20B
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-$1.26B
Total Cash
$15.37B
Debt to Equity
0.21
Issuance of Debt (TTM)
-$1.26B
Repayment of Debt (TTM)
-$1.26B

Key Statistics

Open
$13.11
Close
-
Volume / Avg.
282.33K / 2.44M
Day Range
$13.11 - $13.33
52 Wk Range
12.19 - 16.17
Market Cap
$11.05B
P/E Ratio
24.56
Dividend Yield
0.63%
Exchange
NYSE
RSI
47
Short Interest
3.26%
Days to Cover
13.11

About

Sector
Health Care
Industry
Pharmaceuticals
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond sim...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Dr Reddy's Laboratories (RDY) stock?

A

You can purchase shares of Dr Reddy's Laboratories (NYSE:RDY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Dr Reddy's Laboratories (RDY) competitors?

A

There are no as such competitors for Dr Reddy's Laboratories.

Q

What is the forecast, or price target, for Dr Reddy's Laboratories (RDY) stock?

A

Dr Reddy's Laboratories has a consensus price target of $16.95.

Q

What is the current price for Dr Reddy's Laboratories (RDY)?

A

The stock price for Dr Reddy's Laboratories (NYSE: RDY) is $13.265 last updated June 11, 2026 at 11:46 AM EDT.

Q

Does Dr Reddy's Laboratories (RDY) pay a dividend?

A

There are no upcoming dividends for Dr Reddy's Laboratories.

Q

When is Dr Reddy's Laboratories (NYSE:RDY) reporting earnings?

A

Dr Reddy's Laboratories does not have any upcoming earnings scheduled.

Q

Is Dr Reddy's Laboratories (RDY) going to split?

A

There is no upcoming split for Dr Reddy's Laboratories.

Q

What sector and industry does Dr Reddy's Laboratories (RDY) operate in?

A

Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.